Picture of Viatar CTC Solutions logo

VRTT — Viatar CTC Solutions Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-94.44%
3m-92.69%
6m-92.91%
1yr-92.43%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-3370.17%
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 201631st Dec 2017
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2016 / 2017

Blurred out image of Viatar CTC Solutions EPS forecast chart

Profile Summary

Viatar CTC Solutions Inc., formerly Vizio Medical Devices LLC, is a medical technology company. The Company is focused on developing and marketing products to collect cancer cells for molecular diagnostics by others and as cancer therapy, both of which are based on the principle of removing blood-borne circulating tumor cells (CTCs). These CTCs detach from solid tumors and enter the bloodstream carrying the deoxyribonucleic acid (DNA) of the tumor and seeding new tumors. The Company is seeking to commercialize over two products, which utilizes its CTC removal technology, including Viatar Collection System for Molecular Analysis, which collects and purifies a quantity of CTCs from approximately 50 milliliters of blood as the front end for DNA sequencing and other genetic analysis technologies used primarily for research, and Viatar Therapeutic Oncopheresis System, which removes CTCs from a patient's blood as a cancer therapy for metastatic disease.

Directors

Last Annual
December 31st, 2015
Last Interim
September 30th, 2016
Incorporated
December 18th, 2007
Public Since
May 5th, 2015
No. of Employees
8
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
19,495,426
Blurred out image of a map
Address
116 John St Ste 10, LOWELL, 01852-1124
Web
http://www.viatarctcsolutions.com/
Phone
+1 6172996590
Auditors
Rosenberg, Rich, Baker, Berman & Company

VRTT Share Price Performance

Upcoming Events for VRTT

Similar to VRTT

20/20 Genesystems

us flag iconPink Sheets on Nasdaq

Picture of Accelera Innovations logo

Accelera Innovations

us flag iconPink Sheets on Nasdaq

Accustem Sciences

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ

Or unlock with your email

Or unlock with your email